Bridgeway Capital Management LLC Has $7.96 Million Stock Holdings in Owens & Minor, Inc. (NYSE:OMI)

Bridgeway Capital Management LLC lessened its holdings in shares of Owens & Minor, Inc. (NYSE:OMI) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 608,621 shares of the company’s stock after selling 22,745 shares during the period. Bridgeway Capital Management LLC’s holdings in Owens & Minor were worth $7,955,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of OMI. Sterling Capital Management LLC raised its position in Owens & Minor by 758.3% during the 4th quarter. Sterling Capital Management LLC now owns 2,060 shares of the company’s stock worth $27,000 after purchasing an additional 1,820 shares during the last quarter. Blue Trust Inc. lifted its stake in shares of Owens & Minor by 57.4% in the fourth quarter. Blue Trust Inc. now owns 4,387 shares of the company’s stock worth $57,000 after acquiring an additional 1,600 shares during the period. KBC Group NV boosted its holdings in Owens & Minor by 98.2% in the fourth quarter. KBC Group NV now owns 4,434 shares of the company’s stock valued at $58,000 after acquiring an additional 2,197 shares during the last quarter. Guggenheim Capital LLC acquired a new stake in Owens & Minor during the 4th quarter valued at approximately $166,000. Finally, Optimize Financial Inc acquired a new position in shares of Owens & Minor in the 4th quarter worth approximately $184,000. Institutional investors and hedge funds own 98.04% of the company’s stock.

Insider Activity at Owens & Minor

In related news, major shareholder Coliseum Capital Management, L acquired 1,738,511 shares of the company’s stock in a transaction on Friday, February 28th. The shares were acquired at an average cost of $9.39 per share, for a total transaction of $16,324,618.29. Following the purchase, the insider now owns 9,469,698 shares in the company, valued at approximately $88,920,464.22. The trade was a 22.49 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. In the last quarter, insiders have acquired 2,718,412 shares of company stock valued at $24,495,308. 3.69% of the stock is owned by corporate insiders.

Owens & Minor Trading Down 5.5 %

Shares of Owens & Minor stock opened at $7.73 on Wednesday. The stock has a market capitalization of $597.18 million, a PE ratio of -11.89, a price-to-earnings-growth ratio of 0.20 and a beta of 1.38. Owens & Minor, Inc. has a 52 week low of $6.07 and a 52 week high of $21.02. The stock has a 50 day moving average price of $8.27 and a two-hundred day moving average price of $10.92. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Friday, February 28th. The company reported $0.55 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.02. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business had revenue of $2.70 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same quarter in the previous year, the business posted $0.69 EPS. Owens & Minor’s quarterly revenue was up 1.5% on a year-over-year basis. As a group, equities analysts anticipate that Owens & Minor, Inc. will post 1.51 earnings per share for the current fiscal year.

Owens & Minor declared that its board has authorized a stock repurchase program on Friday, February 28th that permits the company to buyback $100.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 13.6% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on OMI. Citigroup lowered their target price on shares of Owens & Minor from $13.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, April 17th. Robert W. Baird boosted their price objective on Owens & Minor from $10.00 to $11.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd. UBS Group decreased their target price on Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Finally, JPMorgan Chase & Co. dropped their price target on Owens & Minor from $14.00 to $10.00 and set an “underweight” rating on the stock in a research note on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Owens & Minor currently has a consensus rating of “Hold” and a consensus price target of $12.50.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.